Načítá se...
Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
New onset refractory status epilepticus (NORSE) was defined by the International League Against Epilepsy as occurring in patients presenting without a prior diagnosis of epilepsy or other neurological disease, with seizures that persist beyond 24 h. There is still a need to develop new treatment str...
Uloženo v:
| Vydáno v: | Epilepsy Behav Rep |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7972955/ https://ncbi.nlm.nih.gov/pubmed/33748736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebr.2021.100431 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|